• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

全身溶栓作为COVID-19相关急性主髂动脉和下肢动脉血栓形成的初始治疗方法

Systemic Thrombolysis as Initial Treatment of COVID-19 Associated Acute Aortoiliac and Lower Extremity Arterial Thrombosis.

作者信息

Patel Priya, Yu Yasong, Zia Saqib, Padberg Frank, Curi Michael, Huang Joe

机构信息

Division of Vascular Surgery, Rutgers University, New Jersey Medical School, Newark, NJ.

Division of Vascular Surgery, Rutgers University, New Jersey Medical School, Newark, NJ.

出版信息

Ann Vasc Surg. 2021 Jan;70:297-301. doi: 10.1016/j.avsg.2020.08.083. Epub 2020 Aug 28.

DOI:10.1016/j.avsg.2020.08.083
PMID:32861850
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7453212/
Abstract

SARS-CoV-2 (COVID-19) patients with associated thromboembolic events have demonstrated poor outcomes despite the use of anticoagulation therapy and surgical intervention. We present a COVID-19 patient with acute limb ischemia, secondary to extensive thrombosis of an aortic aneurysm, iliac arteries, and infrainguinal arteries. Initial treatment with systemic thrombolysis, which restored patency of the aortoiliac occlusion, was followed by open thrombectomies of the infrainguinal occlusions.

摘要

尽管使用了抗凝治疗和手术干预，但伴有血栓栓塞事件的严重急性呼吸综合征冠状病毒2（SARS-CoV-2，即新型冠状病毒肺炎）患者的预后仍然较差。我们报告了一名新型冠状病毒肺炎患者，其因主动脉瘤、髂动脉和腹股沟下动脉广泛血栓形成继发急性肢体缺血。最初采用全身溶栓治疗，恢复了主髂动脉闭塞的通畅，随后对腹股沟下闭塞进行了切开取栓术。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6411/7453212/94fc61c6c9ec/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6411/7453212/61038ba6ef34/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6411/7453212/94fc61c6c9ec/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6411/7453212/61038ba6ef34/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6411/7453212/94fc61c6c9ec/gr2_lrg.jpg

相似文献

1
Systemic Thrombolysis as Initial Treatment of COVID-19 Associated Acute Aortoiliac and Lower Extremity Arterial Thrombosis.全身溶栓作为COVID-19相关急性主髂动脉和下肢动脉血栓形成的初始治疗方法
Ann Vasc Surg. 2021 Jan;70:297-301. doi: 10.1016/j.avsg.2020.08.083. Epub 2020 Aug 28.
2
Catheter-directed thrombolysis for acute limb ischemia caused by native artery occlusion: an experience of a university hospital.导管定向溶栓治疗原发性动脉闭塞所致急性肢体缺血：一所大学医院的经验
J Med Assoc Thai. 2013 Jun;96(6):661-8.
3
Catheter-directed thrombolysis of acute lower extremity arterial thrombosis in a patient with heparin-induced thrombocytopenia.肝素诱导的血小板减少症患者急性下肢动脉血栓形成的导管定向溶栓治疗
Catheter Cardiovasc Interv. 2007 Dec 1;70(7):1046-50. doi: 10.1002/ccd.21304.
4
Intra-arterial thrombolysis of digital artery occlusions in a patient with polycythemia vera.
Vasa. 2017 Jan;46(1):64-66. doi: 10.1024/0301-1526/a000586. Epub 2016 Nov 16.
5
Catheter-Directed Thrombolysis in a Patient with Severe COVID-19 Pneumonia on Extracorporeal Membrane Oxygenation.体外膜肺氧合支持下的重症新型冠状病毒肺炎患者的导管定向溶栓治疗
Semin Thromb Hemost. 2020 Oct;46(7):850-852. doi: 10.1055/s-0040-1715457. Epub 2020 Sep 4.
6
Initial results of reteplase in the treatment of acute lower extremity arterial occlusions.
J Vasc Interv Radiol. 2000 Mar;11(3):289-94. doi: 10.1016/s1051-0443(07)61419-5.
7
Dethrombosis of lower extremity thrombus by local delivery of thrombolysis using ClearWay transcatheter balloon irrigation: a feasibility study.使用ClearWay经导管球囊冲洗进行局部溶栓治疗下肢血栓的去血栓形成：一项可行性研究。
Cardiovasc Revasc Med. 2011 Nov-Dec;12(6):350-4. doi: 10.1016/j.carrev.2011.06.002.
8
Acute aortoiliac occlusion in a patient with novel coronavirus disease-2019.新型冠状病毒病患者的急性主髂动脉闭塞。
J Vasc Surg. 2021 Jan;73(1):18-21. doi: 10.1016/j.jvs.2020.10.018. Epub 2020 Oct 17.
9
[Low-dose thrombolysis using rt-Pa in extensive peripheral vascular occlusion].[使用重组组织型纤溶酶原激活剂进行低剂量溶栓治疗广泛外周血管闭塞]
Rofo. 2000 Dec;172(12):1028-34. doi: 10.1055/s-2000-9225.
10
Fibrinogen level as a surrogate for the outcome of thrombolytic therapy using tissue plasminogen activator for acute lower extremity intravascular thrombosis.纤维蛋白原水平作为使用组织型纤溶酶原激活剂治疗急性下肢血管内血栓形成溶栓治疗结果的替代指标。
Vasc Endovascular Surg. 2013 Oct;47(7):519-23. doi: 10.1177/1538574413497107. Epub 2013 Jul 29.

引用本文的文献

1
Acute Limb Ischemia in COVID-19: A Systematic Review.新型冠状病毒肺炎相关急性肢体缺血：一项系统综述
Int J Angiol. 2023 Aug 14;32(4):215-226. doi: 10.1055/s-0043-1771250. eCollection 2023 Dec.
2
COVID-Related Thrombosis and Overall Implications Related to Percutaneous Interventions.新冠相关血栓形成及与经皮介入治疗相关的总体影响
Semin Intervent Radiol. 2022 Dec 20;39(5):523-525. doi: 10.1055/s-0042-1758111. eCollection 2022 Oct.
3
SARS-CoV-2 Infection-Associated Aortic Thrombosis Treated with Oral Factor Xa Inhibition.口服Xa因子抑制剂治疗与SARS-CoV-2感染相关的主动脉血栓形成

本文引用的文献

1
Thrombosis in Hospitalized Patients With COVID-19 in a New York City Health System.在纽约市医疗系统中 COVID-19 住院患者中的血栓形成。
JAMA. 2020 Aug 25;324(8):799-801. doi: 10.1001/jama.2020.13372.
2
Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19.新型冠状病毒肺炎的肺血管内皮细胞炎症、血栓形成和血管生成。
N Engl J Med. 2020 Jul 9;383(2):120-128. doi: 10.1056/NEJMoa2015432. Epub 2020 May 21.
3
Acute limb ischaemia in two young, non-atherosclerotic patients with COVID-19.两名非动脉粥样硬化的年轻新冠病毒肺炎患者发生急性肢体缺血。
Case Rep Hematol. 2022 Aug 25;2022:7805900. doi: 10.1155/2022/7805900. eCollection 2022.
4
Management of acute aortoiliac arterial thrombosis in patients with the novel coronavirus disease 2019: A case series and systematic review of the literature.2019年新型冠状病毒病患者急性主-髂动脉血栓形成的管理：病例系列及文献系统评价
Ann Vasc Surg Brief Rep Innov. 2022 Sep;2(3):100105. doi: 10.1016/j.avsurg.2022.100105. Epub 2022 Jul 6.
5
Acute aortic occlusion associated with COVID-19: A rare complication of a not so rare disease.与新型冠状病毒肺炎相关的急性主动脉闭塞：一种并不罕见的疾病的罕见并发症。
J Am Coll Emerg Physicians Open. 2022 Apr 29;3(3):e12730. doi: 10.1002/emp2.12730. eCollection 2022 Jun.
6
Top 10 acral skin manifestations associated with COVID-19: A scoping review.与 COVID-19 相关的十大肢端皮肤表现：范围综述。
Dermatol Ther. 2021 Nov;34(6):e15157. doi: 10.1111/dth.15157. Epub 2021 Oct 21.
7
COVID-19 and Peripheral Artery Thrombosis: A Mini Review.COVID-19 与外周动脉血栓形成：小型综述。
Curr Probl Cardiol. 2022 Oct;47(10):100992. doi: 10.1016/j.cpcardiol.2021.100992. Epub 2021 Sep 24.
8
COVID-19 and peripheral arterial complications in people with diabetes and hypertension: A systematic review.COVID-19 与糖尿病和高血压患者外周动脉并发症：系统评价。
Diabetes Metab Syndr. 2021 Sep-Oct;15(5):102204. doi: 10.1016/j.dsx.2021.102204. Epub 2021 Jul 9.
9
From cellular function to global impact: the vascular perspective on COVID-19.从细胞功能到全球影响：COVID-19 的血管视角。
Can J Surg. 2021 May 12;64(3):E289-E297. doi: 10.1503/cjs.023820.
10
Considerations for Patients With Peripheral Artery Disease During the COVID-19 Pandemic.外周动脉疾病患者在 COVID-19 大流行期间的注意事项。
Clin Appl Thromb Hemost. 2021 Jan-Dec;27:1076029620986877. doi: 10.1177/1076029620986877.
Lancet. 2020 May 16;395(10236):1546. doi: 10.1016/S0140-6736(20)31051-5. Epub 2020 May 5.
4
Risk of peripheral arterial thrombosis in COVID-19.新型冠状病毒肺炎患者外周动脉血栓形成的风险
J Vasc Surg. 2020 Aug;72(2):756-757. doi: 10.1016/j.jvs.2020.04.477. Epub 2020 May 7.
5
Coagulation abnormalities and thrombosis in patients with COVID-19.新型冠状病毒肺炎患者的凝血异常与血栓形成
Lancet Haematol. 2020 Jun;7(6):e438-e440. doi: 10.1016/S2352-3026(20)30145-9. Epub 2020 May 11.
6
Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19: An updated analysis.确认 COVID-19 重症 ICU 患者的血栓并发症累积发生率较高：更新分析。
Thromb Res. 2020 Jul;191:148-150. doi: 10.1016/j.thromres.2020.04.041. Epub 2020 Apr 30.
7
Acute limb ischemia in patients with COVID-19 pneumonia.新型冠状病毒肺炎患者的急性肢体缺血
J Vasc Surg. 2020 Dec;72(6):1864-1872. doi: 10.1016/j.jvs.2020.04.483. Epub 2020 Apr 29.
8
Large-Vessel Stroke as a Presenting Feature of Covid-19 in the Young.大血管卒中作为年轻人新冠病毒病的首发特征
N Engl J Med. 2020 May 14;382(20):e60. doi: 10.1056/NEJMc2009787. Epub 2020 Apr 28.
9
Incidence of thrombotic complications in critically ill ICU patients with COVID-19.COVID-19 重症监护病房危重症患者的血栓并发症发生率。
Thromb Res. 2020 Jul;191:145-147. doi: 10.1016/j.thromres.2020.04.013. Epub 2020 Apr 10.
10
Tissue plasminogen activator (tPA) treatment for COVID-19 associated acute respiratory distress syndrome (ARDS): A case series.组织型纤溶酶原激活物（tPA）治疗 COVID-19 相关急性呼吸窘迫综合征（ARDS）：病例系列。
J Thromb Haemost. 2020 Jul;18(7):1752-1755. doi: 10.1111/jth.14828. Epub 2020 May 11.